DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Stone R, Mandrekar S, Sanford BL et al.
The Multi-Kinase Inhibitor Midostaurin (M) Prolongs Survival Compared with Placebo (P) in Combination with Daunorubicin (D)/Cytarabine (C) Induction (ind), High-Dose C Consolidation (consol), and As Maintenance (maint) Therapy in Newly Diagnosed Acute Myeloid Leukemia (AML) Patients (pts) Age 18–60 with FLT3 Mutations (muts): An International Prospective Randomized (rand) P-Controlled Double-Blind Trial (CALGB 10 603/RATIFY [Alliance]).
ASH 2015 abstract #6
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.